Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy

Published:2020-01 Issue:1 Volume:42 Page:77-93
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Yan Tingjian,Greene Mallik,Chang Eunice,Houle Christy R.,Waters Heidi C.,Tarbox Marian H.,Broder Michael S.

Funder

Otsuka Pharmaceutical Development & Commercialization, Inc.

Lundbeck

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. The economic burden of schizophrenia in the United States in 2013;Cloutier;J Clin Psychiatr,2016

2. The cost of relapse and the predictors of relapse in the treatment of schizophrenia;Ascher-Svanum;BMC Psychiatry,2010

3. Practice guideline for the treatment of patients with schizophrenia, second edition;Lehman;Am J Psychiatr,2004

4. Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA;Aigbogun;Clin Outcomes Res,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of the real-world effectiveness and economic and humanistic outcomes of selected oral antipsychotics among patients with schizophrenia in the United States: Updating the evidence and gaps;Journal of Managed Care & Specialty Pharmacy;2024-02-03

2. Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders;Journal of Clinical Medicine;2022-08-03

3.

Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective

;Drug Design, Development and Therapy;2020-12

4. Brexpiprazole reduces costs of psychiatric care in the US;PharmacoEconomics & Outcomes News;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3